Your browser doesn't support javascript.
loading
Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT.
Castello, Angelo; Rossi, Sabrina; Mazziotti, Emanuela; Toschi, Luca; Lopci, Egesta.
  • Castello A; Department of Nuclear Medicine, Humanitas Clinical and Research Center, IRCCS, Milan, Italy; and.
  • Rossi S; Department of Oncology and Hematology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
  • Mazziotti E; Department of Nuclear Medicine, Humanitas Clinical and Research Center, IRCCS, Milan, Italy; and.
  • Toschi L; Department of Oncology and Hematology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
  • Lopci E; Department of Nuclear Medicine, Humanitas Clinical and Research Center, IRCCS, Milan, Italy; and egesta.lopci@humanitas.it.
J Nucl Med ; 61(6): 821-826, 2020 06.
Article en En | MEDLINE | ID: mdl-31862803
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Fluorodesoxiglucosa F18 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Fluorodesoxiglucosa F18 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article